Literature DB >> 19376220

Oxidative stress-induced changes in pyridine nucleotides and chemoattractant 5-lipoxygenase products in aging neutrophils.

François D Graham1, Karl-Rudolf Erlemann, Sylvie Gravel, Joshua Rokach, William S Powell.   

Abstract

Neutrophils spontaneously undergo apoptosis, which is associated with increased oxidative stress. We found that there is a dramatic shift in the formation of 5-lipoxygenase products during this process. Freshly isolated neutrophils rapidly convert leukotriene B(4) (LTB(4)) and 5-hydroxy-6,8,11,14-eicosatetraenoic acid (5-HETE) to their biologically inactive omega-oxidation products. However, omega-oxidation is impaired in neutrophils cultured for 24 h, when only 25% of the cells are nonapoptotic, resulting in the persistence of LTB(4) and a dramatic shift in 5-HETE metabolism to the potent granulocyte chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE). The reduced omega-oxidation activity seems to be due to a reduction in LTB(4) 20-hydroxylase activity, whereas the increased 5-oxo-ETE formation is caused by a dramatic increase in the 5-hydroxyeicosanoid dehydrogenase cofactor NADP(+). NAD(+), but not NADPH, also increased, as did the GSSG/GSH ratio, indicative of oxidative stress. The changes in 5-HETE metabolism and pyridine nucleotides were inhibited by antiapoptotic agents (GM-CSF, forskolin) and antioxidants (diphenylene iodonium, catalase, deferoxamine), suggesting the involvement of H(2)O(2) and possibly other reactive oxygen species. These results suggest that in severe inflammation, aging neutrophils that have evaded rapid uptake by macrophages may produce increased amounts of the chemoattractants 5-oxo-ETE and LTB(4), resulting in delayed resolution or exacerbation of the inflammatory process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19376220      PMCID: PMC2891157          DOI: 10.1016/j.freeradbiomed.2009.04.016

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  49 in total

1.  Induction of neutrophil apoptosis and secondary necrosis during endotoxin-induced pulmonary inflammation in mice.

Authors:  Djordje Medan; Liying Wang; Xiaodong Yang; Sujatha Dokka; Vincent Castranova; Yon Rojanasakul
Journal:  J Cell Physiol       Date:  2002-06       Impact factor: 6.384

Review 2.  Granulocyte apoptosis and its role in the resolution and control of lung inflammation.

Authors:  C Haslett
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

Review 3.  Leukotriene B4 receptors.

Authors:  Akiko Toda; Takehiko Yokomizo; Takao Shimizu
Journal:  Prostaglandins Other Lipid Mediat       Date:  2002-08       Impact factor: 3.072

4.  Endothelial cells modulate eosinophil surface markers and mediator release.

Authors:  M J Dallaire; C Ferland; N Pagé; S Lavigne; F Davoine; M Laviolette
Journal:  Eur Respir J       Date:  2003-06       Impact factor: 16.671

Review 5.  Free radicals in the physiological control of cell function.

Authors:  Wulf Dröge
Journal:  Physiol Rev       Date:  2002-01       Impact factor: 37.312

Review 6.  Redox regulation of neutrophil apoptosis.

Authors:  R W G Watson
Journal:  Antioxid Redox Signal       Date:  2002-02       Impact factor: 8.401

7.  Expression and characterization of a 5-oxo-6E,8Z,11Z,14Z-eicosatetraenoic acid receptor highly expressed on human eosinophils and neutrophils.

Authors:  Carol E Jones; Suzanne Holden; Laurent Tenaillon; Umesh Bhatia; Klaus Seuwen; Pamela Tranter; Jonathan Turner; Rachel Kettle; Rochdi Bouhelal; Steven Charlton; N R Nirmala; Gabor Jarai; Peter Finan
Journal:  Mol Pharmacol       Date:  2003-03       Impact factor: 4.436

Review 8.  Neutrophil apoptosis pathways and their modifications in inflammation.

Authors:  Hans-Uwe Simon
Journal:  Immunol Rev       Date:  2003-06       Impact factor: 12.988

9.  Effects of metabolites of leukotriene B4 on human neutrophil migration and cytosolic calcium levels.

Authors:  W S Powell; J Rokach; S P Khanapure; S Manna; M Hashefi; S Gravel; R J Macleod; J R Falck; R K Bhatt
Journal:  J Pharmacol Exp Ther       Date:  1996-02       Impact factor: 4.030

10.  Identification of a novel human eicosanoid receptor coupled to G(i/o).

Authors:  Takeshi Hosoi; Yutaka Koguchi; Emiko Sugikawa; Aiko Chikada; Koji Ogawa; Naoki Tsuda; Naoki Suto; Shiho Tsunoda; Tomoyasu Taniguchi; Tetsuo Ohnuki
Journal:  J Biol Chem       Date:  2002-06-13       Impact factor: 5.157

View more
  14 in total

1.  Uroporphyria in the Cyp1a2-/- mouse.

Authors:  John D Phillips; James P Kushner; Hector A Bergonia; Michael R Franklin
Journal:  Blood Cells Mol Dis       Date:  2011-08-30       Impact factor: 3.039

2.  In vivo α-hydroxylation of a 2-alkylindole antagonist of the OXE receptor for the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid in monkeys.

Authors:  Shishir Chourey; Qiuji Ye; Chintam Nagendra Reddy; Chantal Cossette; Sylvie Gravel; Matthias Zeller; Irina Slobodchikova; Dajana Vuckovic; Joshua Rokach; William S Powell
Journal:  Biochem Pharmacol       Date:  2017-05-03       Impact factor: 5.858

3.  Biosynthesis and actions of 5-oxoeicosatetraenoic acid (5-oxo-ETE) on feline granulocytes.

Authors:  Chantal Cossette; Sylvie Gravel; Chintam Nagendra Reddy; Vivek Gore; Shishir Chourey; Qiuji Ye; Nathaniel W Snyder; Clementina A Mesaros; Ian A Blair; Jean-Pierre Lavoie; Carol R Reinero; Joshua Rokach; William S Powell
Journal:  Biochem Pharmacol       Date:  2015-05-29       Impact factor: 5.858

4.  Inhibition of 5-oxo-6,8,11,14-eicosatetraenoic acid-induced activation of neutrophils and eosinophils by novel indole OXE receptor antagonists.

Authors:  Vivek Gore; Sylvie Gravel; Chantal Cossette; Pranav Patel; Shishir Chourey; Qiuji Ye; Joshua Rokach; William S Powell
Journal:  J Med Chem       Date:  2014-01-06       Impact factor: 7.446

Review 5.  The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor.

Authors:  William S Powell; Joshua Rokach
Journal:  Prog Lipid Res       Date:  2013-09-19       Impact factor: 16.195

Review 6.  Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid.

Authors:  William S Powell; Joshua Rokach
Journal:  Biochim Biophys Acta       Date:  2014-10-29

7.  Enhanced formation of 5-oxo-6,8,11,14-eicosatetraenoic acid by cancer cells in response to oxidative stress, docosahexaenoic acid and neutrophil-derived 5-hydroxy-6,8,11,14-eicosatetraenoic acid.

Authors:  Gail E Grant; Stephen Rubino; Sylvie Gravel; Xiaoping Wang; Pranav Patel; Joshua Rokach; William S Powell
Journal:  Carcinogenesis       Date:  2011-03-10       Impact factor: 4.944

8.  Targeting the OXE receptor with a selective antagonist inhibits allergen-induced pulmonary inflammation in non-human primates.

Authors:  Chantal Cossette; Lisa A Miller; Qiuji Ye; Shishir Chourey; Chintam Nagendra Reddy; Joshua Rokach; William S Powell
Journal:  Br J Pharmacol       Date:  2021-12-16       Impact factor: 8.739

Review 9.  5-Oxo-ETE and the OXE receptor.

Authors:  Gail E Grant; Joshua Rokach; William S Powell
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-05-18       Impact factor: 3.072

10.  Deferasirox reduces oxidative stress in patients with transfusion dependency.

Authors:  Katsuyasu Saigo; Mari Kono; Yuri Takagi; Mariko Takenokuchi; Yasushi Hiramatsu; Hiroshi Tada; Terutoshi Hishita; Masahito Misawa; Shion Imoto; Shinsaku Imashuku
Journal:  J Clin Med Res       Date:  2013-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.